Enter assignee name

Forward Citations = 23

Loading Chart...

4 inventors (with patents filed for the assignee):

Louis Habash (5 out of 5 patents)

Clarence Jones (5 out of 5 patents)

Peter C Hoyle (1 out of 3 patents)

4. Kameron W Maxwell (1 out of 1 patent)

6 patents: Sort by Forward Citations

1. 10245256 - Nitroxides for use in treating or preventing diabetes and obesity (2019-04-02),

2. 9522144 - Nitroxides for use in treating or preventing diabetes and obesity (2016-12-20),

3. 9522143 - Nitroxides for use in treating or preventing diabetes and obesity (2016-12-20),

4. 9101619 - Nitroxides for use in treating or preventing diabetes and obesity (2015-08-11),

5. 8563581 - Nitroxides for use in treating predisposed or at risk patients (2013-10-22),

6. 7625928 - Nitroxide radioprotector formulations and methods of use (2009-12-01),

Mitos Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing innovative therapies for rare genetic disorders. With a strong commitment to advancing precision medicine, Mitos is dedicated to improving the lives of patients through groundbreaking research and development. Our pipeline includes potential treatments for a range of genetic conditions, with a particular focus on rare diseases with significant unmet medical needs.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 23 2025

6 Patents

#60 in Newport Beach, CA

#10,286 in California

#43,751 in US

Newport Beach, CA, United States of America

Mitos Pharmaceuticals, Inc.

Forward Citations = 23

4 inventors:

Louis Habash (5 out of 5 patents)

Clarence Jones (5 out of 5 patents)

Peter C Hoyle (1 out of 3 patents)

4. Kameron W Maxwell (1 out of 1 patent)

Please report any incorrect information to support@idiyas.com